
Lunit receives approval for 3D breast tomosynthesis AI solution
Lunit, a Korean medical AI imaging company, said it obtained approval from the Ministry of Food and Drug Safety (MFDS) for its 3D breast tomosynthesis AI analysis solution, Lunit INSIGHT DBT (digital breast tomosynthesis). The software supports physicians …